[28] Use and specificity of staurosporine, UCN-O1, and calphostin C as protein kinase inhibitors
- 1 January 1991
- book chapter
- Published by Elsevier in Methods in Enzymology
- Vol. 201, 340-347
- https://doi.org/10.1016/0076-6879(91)01030-6
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1989
- Staurosporine, a protein kinase C inhibitor, attenuates Ca2+-dependent stretch-induced vascular toneBiochemical and Biophysical Research Communications, 1989
- Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potein inhibitor of insulin receptor than IGF-I receptorBiochemical and Biophysical Research Communications, 1988
- The molecular heterogeneity of protein kinase C and its implications for cellular regulationNature, 1988
- A thousand and one protein kinasesCell, 1987
- Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60.The Journal of Antibiotics, 1987
- Studies and Perspectives of Protein Kinase CScience, 1986
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986
- Staurosporine-induced differentiation in a human neuroblastoma cell line, NB-1.Agricultural and Biological Chemistry, 1985
- Activation of protein kinase C by non-phorbol tumor promoter, mezereinBiochemical and Biophysical Research Communications, 1984